FeverGuard
FeverGuard is a small, wearable thermometer that fits comfortably on the upper arm. It provides an early warning of a potential fever, one of the most common signs of an infection.
Mark Lewis, technology executive and CEO with over 30 years of industry experience. Accomplished leader that has grown several new businesses to more than $250M and managed several multi-billion-dollar divisions.
- Identify (Determine & limit the disease risk pool & spill over risk), such as: Genomic data to predict emerging risk, Early warning through ecological, behavioural & other data, Intervention/Incentives to reduce risk for emergency & spill over
Fever is one of the most common symptoms of a viral or bacterial infection yet (until FeverGuard) there was no easy way to monitor individuals for the first sign of a fever. Several challenges needed to be overcome.
First, we needed to create a comfortable wearable solution that could continuously monitor body temperature. The FeverGuard team has tested several methods of taking temperature measurements as close to the ideal core body locations as possible. Axillary measurement offers the most consistently accurate results. Many Bluetooth temperature devices worn on the wrist provide poor, inaccurate, and inconsistent temperature measurements compared to core temperatures. We built a simple small bluetooth device the attaches to the upper arm for this purpose.
Our research also showed that each individual's "normal" temperature could vary by as much as 4 degrees and that an individual's temperature could also vary by up to 3 degrees throughout the day (circadian rhythm). To rapidly detect the onset of a fever we needed a solution the could rapidly "learn" an individual's temperature pattern so that we could focus on anomaly detection so the we could alert the user at the first sign of an elevated temperature.
Simply put, what might be a normal temperature for one person might be an abnormally high temperature for another person.
Using our solution all individuals will be able to monitor themselves for the first sign of a fever. This will reduce the spread of a virus and allow for faster time to treatment.
While FeverGuard can be used by anyone, our focus is on the essential workforce during a pandemic.
Members of the essential workforce, comprising 62 million primarily women and underrepresented minorities (URMs), face a stark choice: keep working or lose their jobs.
Many jobs require close physical proximity to others and frequent face-to-face interactions that increase potential disease exposure. Physical distancing is an unattainable luxury. Essential workers expose themselves and their families to the COVID virus every day. For them, the economy never closed.
So, essential workers live in fear as they struggle with mental and physical health problems caused by constant stress, frequently exacerbated by sleep disorders.
Much of our development testing has been done with police, fire and healthcare professionals.
Feverguard has applicability in any situation where individuals are at risk for contracting a virus and spreading it to others.
- Growth: An initiative, venture, or organisation with an established product, service, or business/policy model rolled out in one or, ideally, several contexts or communities, which is poised for further growth
- Artificial Intelligence / Machine Learning
- Internet of Things
- Software and Mobile Applications
This system provides a great benefit to both the wearer and those close to them by providing the earliest possible warning of a fever that might be caused by a contagious virus. This system can reduce the spread of a virus as well as provide an early warning to individuals so they can seek testing and/or treatment.
There are many sets of individuals that are either at significant risk of exposure to a virus (such as essential workers) or have underlying conditions (such as the elderly) that increase their risk to a given virus. Our solution aids in provide a a low cost way to provide an early indication of a potential issue.
Our product has just gone into production and we are working to make it available widely in the general market. The system is easily scaleable to millions of users and is HIPPA compliant.
We have the ability (in aggregate) to evaluate the number of temperature anomaly events (potential fevers) detected. We will use this data in-conjunction with feedback surveys to determine our level of efficacy.
Our other success metric is simply our ability to grows sales volume as well as establish multiple use case for the solution.
Our pilot testing have proven our product to be 100% effective at detecting a potential fever. We have also proven out the comfort of the wearable and ease of use of the phone application.
- Canada
- United States
- France
- Germany
- Mexico
- United Kingdom
We have faced some concerns over data privacy which we believe we have addressed. All individual temperate data is accessible only by the direct user.
We also require additional capital to expand operations.
We do not face any significant infrastructure or distribution challenges.
- For-profit, including B-Corp or similar models
We have advisors from Stanford and other institutions but no other formal affiliations.
In addition to capital, we face the challenge of navigating a complex healthcare environment. From dealing with regulations, to privacy concerns and other issues we face a number of core challenges where additional support would be greatly beneficial.
We are looking for partners that can:
- help with expansion of distribution into healthcare
- help us refine our message to alleviate individual concerns
- build institution and government awareness of our solution as a potential aid in stemming the spread of future viruses